Gorlin Syndrome

From WikiMD's Wellnesspedia

Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome (NBCCS), is a rare genetic disorder characterized by the development of multiple basal cell carcinomas (BCCs), odontogenic keratocysts in the jaw, and a variety of other physical abnormalities. This condition is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. The gene associated with Gorlin Syndrome is the PTCH1 gene, located on chromosome 9q22.3. Mutations in this gene lead to the development of the syndrome's characteristic features.

Symptoms and Characteristics[edit | edit source]

Gorlin Syndrome presents a wide range of clinical manifestations. The most common include:

  • Basal Cell Carcinomas: Individuals with Gorlin Syndrome typically develop numerous basal cell carcinomas over their lifetime. These skin cancers usually appear in adolescence or early adulthood but can occur at any age.
  • Odontogenic Keratocysts: These are cysts that occur in the jaw and can cause swelling or displacement of teeth. They often recur after removal.
  • Palmar or Plantar Pits: Small pits in the palms of the hands and soles of the feet.
  • Calcification of the Falx Cerebri: An abnormal calcification of the brain, which does not usually cause symptoms.
  • Skeletal Abnormalities: These can include rib anomalies, scoliosis, and other bone deformities.
  • Macrocephaly: An abnormally large head size, often with a prominent forehead.

Other features may include eye abnormalities, such as cataracts, developmental disabilities, and an increased risk of developing other types of tumors, including medulloblastoma, a type of brain tumor.

Diagnosis[edit | edit source]

Diagnosis of Gorlin Syndrome is based on clinical examination and the presence of characteristic features. Genetic testing for mutations in the PTCH1 gene can confirm the diagnosis. Diagnostic criteria have been established, requiring the presence of two major criteria or one major and two minor criteria for a diagnosis.

Treatment[edit | edit source]

There is no cure for Gorlin Syndrome, but treatment is available for the management of symptoms and prevention of new basal cell carcinomas. Management strategies include:

  • Regular skin examinations to detect and treat basal cell carcinomas early.
  • Surgical removal of basal cell carcinomas and odontogenic keratocysts.
  • Use of retinoids, which may reduce the number of new basal cell carcinomas.
  • Avoidance of sunlight and use of sunscreen to reduce the risk of skin cancers.
  • Monitoring for the development of other tumors and treating them as necessary.

Genetics[edit | edit source]

Gorlin Syndrome is caused by mutations in the PTCH1 gene, which plays a key role in the Hedgehog signaling pathway, a pathway involved in the regulation of cell growth and development. Mutations in this gene lead to the uncontrolled cell growth characteristic of the syndrome.

Epidemiology[edit | edit source]

Gorlin Syndrome is a rare condition, with an estimated prevalence of 1 in 31,000 to 1 in 256,000 people worldwide. It affects males and females equally.

See Also[edit | edit source]

References[edit | edit source]

Resources[edit source]

Latest articles - Gorlin Syndrome

PubMed
Clinical trials
UpToDate

AI tools[edit source]

Generative AI tools and links to learn more on Gorlin Syndrome: ChatGPT - Bing Chat - Google Gemini. (caution advised).


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Admin, Prab R. Tumpati, MD